FIELD: medicine.
SUBSTANCE: determine the risk factors of the disease TNM stage (I-IV), the tumor type on the Bismuth-Corlette, degree of tumor differentiation, the presence of vascular and perineural invasion, radical surgery. The resulting risk factors assigned scores. Determine the prognostic criteria (P) at the stated formula. If the value of P from 0 to 70% predicted probability of survival for more than 2 years. If the value of P from 71% to 80% - probability of survival of 1-2 years, inclusive. At P 80% - probability of survival less than 1 year.
EFFECT: method allows accurate prediction of overall survival conduct by evaluating the most significant risk factors.
4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA AFTER SURGICAL TREATMENT | 2017 |
|
RU2653810C1 |
| METHOD OF DETERMINATION OF SURVIVAL IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA | 2018 |
|
RU2666208C1 |
| METHOD FOR DETERMINING SURVIVAL IN PATIENTS WITH PROXIMAL BILE DUCT TUMORS DURING PREOPERATIVE STAGE | 2018 |
|
RU2678472C1 |
| METHOD FOR PRE-OPERATIVE DETERMINATION OF PERITONEAL CARCINOSIS PROBABILITY IN PATIENTS WITH PORTAL CHOLANGIOCARCINOMA | 2016 |
|
RU2625898C1 |
| METHOD FOR DETERMINING SURVIVAL OF PATIENTS WITH INTRAHEPAPER CHOLANGIOCELLULAR CANCER IN THE POSTOPERATIVE PERIOD | 2021 |
|
RU2773252C1 |
| METHOD FOR THE TREATMENT OF UNRESECTABLE HYLUS CHOLANGIOCARCINOMA | 2020 |
|
RU2755329C2 |
| METHOD FOR ANALYSING PANCREATIC CANCER, METHOD FOR ANALYSING EXCISED COMPLEX OF ORGANS AND USING IT | 2014 |
|
RU2568766C2 |
| METHOD OF PERCUTANEOUS TRANSHEPATIC PLUCK INTRADUCTAL BIOPSY | 2022 |
|
RU2798679C1 |
| METHOD OF COMBINED TREATMENT OF UNRESECTABLE CANCER OF EXTRAHEPINOUS BILE DUCTS | 2018 |
|
RU2703330C2 |
| METHOD FOR PREDICTION OF RISK OF RECURRENT DISEASE OF SQUAMOUS CELL LUNG CANCER OF STAGE IIB-IIIA IN PATIENTS RECEIVING ADJUVANT POLYCHEMOTHERAPY AFTER RADICAL SURGERY | 2023 |
|
RU2815575C1 |
